Compare Mutual Funds
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹100
-
Expense Ratio
2.34
-
NAV
₹13.59
-
Fund Started
20 Nov 2023
-
Fund Size
₹451.35 Cr
-
Exit Load
0.5% for redemption within 30 Days
-
1 Year
11.72%
-
3 Year
-
-
5 Year
-
-
Equity
98.25%
-
Cash
1.75%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.37% |
Max Healthcare Institute Ltd. | 6.89% |
JB Chemicals & Pharmaceuticals Ltd. | 6.67% |
Divi's Laboratories Ltd. | 6.03% |
Fortis Healthcare Ltd. | 4.91% |
Lupin Ltd. | 4.53% |
Cipla Ltd. | 4.40% |
Acutaas Chemicals Ltd. | 3.81% |
Apollo Hospitals Enterprise Ltd. | 3.08% |
Jubilant Pharmova Ltd. | 3.05% |
-
Name
-
-
Start Date
-
-
Description
The scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.
-
Launch Date
20 Nov 2023
-
